-
Je něco špatně v tomto záznamu ?
Biorelevantní disoluční media simulující podmínky trávicího traktu
[Biorelevant dissolution media simulating conditions in gastrointestinal tract]
Barbora Vraníková, Aleš Franc, Jan Gajdziok, David Vetchý
Jazyk čeština Země Česko
- MeSH
- biologická dostupnost * MeSH
- chemické jevy MeSH
- enzymy MeSH
- gastrointestinální trakt * fyziologie MeSH
- koncentrace vodíkových iontů MeSH
- lékové transportní systémy * MeSH
- lidé MeSH
- rozpustnost * MeSH
- střevní sekrety fyziologie chemie MeSH
- techniky in vitro MeSH
- žaludeční kyselina fyziologie chemie MeSH
- Check Tag
- lidé MeSH
Dissolution test is used for in vitro evaluation of the speed and extent of the drug release from the tested medical form. The traditional dissolution test is often unsuitable for the prediction of the complex drug behavior under in vivo conditions. Biorelevant dissolution media simulate in vivo conditions in the gastrointestinal tract (pH, surface tension, osmolality, buffer capacity, presence of enzymes, etc.), in both the fasting and the fed state. For example, pH of the fasted-state simulated gastric fluid is increased to 1.6 and its maximum recommended volume is 300 mL. Medium also contains bile salt (sodium taurocholate) as the surface active agent. pH of the fasted-state simulated intestinal fluids is decreased to 6.8, and, in addition to sodium taurocholate, this biorelevant medium contains phospholipids (lecithin) which facilitate the wetting of the solids and increase the solubility of lipophilic drugs by micelles formation. The biphasic dissolution medium, which consists of aqueous (classical or biorelevant dissolution medium) and an organic phase (octanol), could be used to simulate drug transfer through biological membranes.
Biorelevant dissolution media simulating conditions in gastrointestinal tract
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16015157
- 003
- CZ-PrNML
- 005
- 20160628092730.0
- 007
- ta
- 008
- 160524s2016 xr ad f 000 0|cze||
- 009
- AR
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Vraníková, Barbora $7 xx0228025 $u Ústav technologie léků, Farmaceutická fakulta, Veterinární a Farmaceutická Univerzita Brno
- 245 10
- $a Biorelevantní disoluční media simulující podmínky trávicího traktu / $c Barbora Vraníková, Aleš Franc, Jan Gajdziok, David Vetchý
- 246 31
- $a Biorelevant dissolution media simulating conditions in gastrointestinal tract
- 504 __
- $a Literatura
- 520 9_
- $a Dissolution test is used for in vitro evaluation of the speed and extent of the drug release from the tested medical form. The traditional dissolution test is often unsuitable for the prediction of the complex drug behavior under in vivo conditions. Biorelevant dissolution media simulate in vivo conditions in the gastrointestinal tract (pH, surface tension, osmolality, buffer capacity, presence of enzymes, etc.), in both the fasting and the fed state. For example, pH of the fasted-state simulated gastric fluid is increased to 1.6 and its maximum recommended volume is 300 mL. Medium also contains bile salt (sodium taurocholate) as the surface active agent. pH of the fasted-state simulated intestinal fluids is decreased to 6.8, and, in addition to sodium taurocholate, this biorelevant medium contains phospholipids (lecithin) which facilitate the wetting of the solids and increase the solubility of lipophilic drugs by micelles formation. The biphasic dissolution medium, which consists of aqueous (classical or biorelevant dissolution medium) and an organic phase (octanol), could be used to simulate drug transfer through biological membranes.
- 650 12
- $a gastrointestinální trakt $x fyziologie $7 D041981
- 650 12
- $a lékové transportní systémy $7 D016503
- 650 12
- $a biologická dostupnost $7 D001682
- 650 12
- $a rozpustnost $7 D012995
- 650 _2
- $a chemické jevy $7 D055598
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a enzymy $7 D004798
- 650 _2
- $a žaludeční kyselina $x fyziologie $x chemie $7 D005744
- 650 _2
- $a střevní sekrety $x fyziologie $x chemie $7 D007419
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Franc, Aleš, $d 1968- $7 mzk2008479726 $u Ústav technologie léků, Farmaceutická fakulta, Veterinární a Farmaceutická Univerzita Brno
- 700 1_
- $a Gajdziok, Jan $7 xx0126570 $u Ústav technologie léků, Farmaceutická fakulta, Veterinární a Farmaceutická Univerzita Brno
- 700 1_
- $a Vetchý, David, $d 1972- $7 mzk2006368163 $u Ústav technologie léků, Farmaceutická fakulta, Veterinární a Farmaceutická Univerzita Brno
- 773 0_
- $t Chemické listy $x 0009-2770 $g Roč. 110, č. 2 (2016), s. 126-132 $w MED00011010
- 856 41
- $u http://www.chemicke-listy.cz/ojs3/index.php/chemicke-listy/article/view/233/233 $y domovská stránka časopisu
- 910 __
- $a ABA008 $b B 1918 $c 395 $y 4 $z 0
- 990 __
- $a 20160523135344 $b ABA008
- 991 __
- $a 20160628092916 $b ABA008
- 999 __
- $a ok $b bmc $g 1125356 $s 939586
- BAS __
- $a 3
- BMC __
- $a 2016 $b 110 $c 2 $d 126-132 $i 0009-2770 $m Chemické listy $n Chem. Listy $x MED00011010
- LZP __
- $c NLK137 $d 20160628 $a NLK 2016-19/pk